Testing effectiveness (Phase 2)Study completedNCT04313023
What this trial is testing
The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
Who this might be right for
COVID-19
Pulmotect, Inc. 217
Showing 20 of 0 results